205. ESTRO update with A/Prof Steven David
About this episode
A/Prof Steven David discusses the latest updates in breast cancer radiation from the ESTRO conference.
This week, we take a quick trip to Stockholm, Sweden, where ESTRO (European Society for Radiotherapy and Oncology) took place several weeks ago. A/Prof Steven David digs deep into the latest updates in the breast cancer radiation space, including hyperfractionation of treatment, the utilisation of AI for radiation planning (Archery Trial), and the DBCG RT Natural Trial, which examined whether omitting partial breast irradiation (PBI) after breast-conserving surgery was safe in those over 60 (spoiler: you should still give PBI). For more episodes, resources and blog posts, visit www.inquisitiveonc.com Please find us on Twitter @InquisitiveOnc! If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com Art courtesy of Taryn Silver Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/ Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice. Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the…
Sponsors
Pfizer, Merck Pharmaceuticals
More episodes of Oncology for the Inquisitive Mind
- 208. ASCO 2026 - The Plenary Episode - Part 3
- 207. ASCO 2026 - Agents of the Future - Part 2
- 206. ASCO 2026 - Part 1
Explore listener stats, chart rankings, contacts and more on the Oncology for the Inquisitive Mind podcast page.